|
|
| MRD / Regn No. |
: 20260000607 |
Date |
: 02/07/2026 |
| Patient Name |
: Swapan Sen |
Age & Gender |
: 58 Yrs. / Male |
| Contact No. |
: 9679477443 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (02/Jul/2011) | MILD TSH ELEVATION (02/Jul/2026) | ERECTILE DYSFUNCTION (02/Jul/2026) | A1G3 DKD (02/Jul/2026) | F1S2 MASLD (02/Jul/2026) | |
|
Subjective |
: |
DM FOR 15 YEARS
|
|
Objective |
: |
NONE |
|
Analysis |
: |
MILD TSH ELEVATION,ERRECTILE DYSFUNCTION,A1G3 DKD,INCREASED FIB 4 SCORE,TYPE 2 DM,F1S2 MASLD |
|
Plan |
: |
START GLP1RA SGLT2I,ADD ARB,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
LIVER CAP: 296 dB/M | LIVER ELASTICITY: 7.7 kPA | LIVER METAVIR SCORE: F1 | LIVER STEATOSIS SCORE: S2 |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION SEMAGLUTIDE 0,25 MG
OBEDA
Medicine For DIABETES HEART AND KIDNEY PROTECTION |
SQ |
ONCE A WEEK |
SUBCUTANEOUS
|
|
| MAY CAUSE NAUSEA VOMITING | |
|
2 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
3 |
TADALAFIL CITRATE 5 MG
MODULA 5 MG
Medicine For ERECTILE DYSFUNCTION |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| NOT TO BE TAKEN IF WITH NITRATE GROUP OF DRUGS (HEART) | |
|
4 |
TELMISARTAN 40 MG
ERITEL 40 MG |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HIGH POTASSIUM | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: AVOID CONJEE SWEETS CHOCOLATES AND SIMPLE SUGARS OF ANY KIND,AVOID OR REDUCE RESTAURANT FOOD,AVOID PROCESSED FOOD,EXERCISE 150 MINUTES PER WEEK,REDUCE CARBOHYDRATE BY 20%,REDUCE SEDENTARY TIME |
| Next Visit |
: 31/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |
|